These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7941276)

  • 21. Edrophonium as an antagonist of vecuronium-induced neuromuscular block in the elderly.
    Kitajima T; Ishii K; Ogata H
    Anaesthesia; 1995 Apr; 50(4):359-61. PubMed ID: 7747859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sevoflurane and isoflurane impair edrophonium reversal of vecuronium-induced neuromuscular block.
    Morita T; Kurosaki D; Tsukagoshi H; Sugaya T; Saito S; Sato H; Fujita T
    Can J Anaesth; 1996 Aug; 43(8):799-805. PubMed ID: 8840059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacology of edrophonium in infants and children.
    Fisher DM; Cronnelly R; Sharma M; Miller RD
    Anesthesiology; 1984 Oct; 61(4):428-33. PubMed ID: 6486504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of neostigmine or edrophonium on force of contraction when administered at a train-of-four ratio of 0.9 in anesthetized dogs.
    Romano M; Martin-Flores M; Sakai DM; Tseng CT; Campoy L; Gleed RD
    Vet Anaesth Analg; 2017 Nov; 44(6):1313-1320. PubMed ID: 29066245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
    Jones RS
    Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autonomic and cardiovascular effects of neuromuscular blockade antagonism in the dog.
    Clutton RE; Boyd C; Flora R; Payne J; McGrath CJ
    Vet Surg; 1992; 21(1):68-75. PubMed ID: 1580060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1986 Nov; 58(11):1285-9. PubMed ID: 2877681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Edrophonium is better than neostigmine to antagonize residual vecuronium induced neuromuscular block.
    Puura AI; Baer GA; Rorarius MG
    Acta Anaesthesiol Belg; 1994; 45(4):161-6. PubMed ID: 7887118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Train-of-four ratio after antagonism of atracurium with edrophonium: influence of different priming doses of edrophonium.
    Naguib M
    Can J Anaesth; 1989 Jan; 36(1):25-9. PubMed ID: 2644050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonism of the muscarinic effects of edrophonium with atropine or glycopyrrolate. A comparative study.
    Mirakhur RK
    Br J Anaesth; 1985 Dec; 57(12):1213-6. PubMed ID: 4084429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of edrophonium and neostigmine for the reversal of mivacurium-induced neuromuscular blockade in sheep.
    Clutton RE; Glasby MA
    Res Vet Sci; 1998; 64(3):265-6. PubMed ID: 9690616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism of neuromuscular blockade. The cardiovascular effects in children of the combination of edrophonium and glycopyrronium.
    Goldhill DR; Pyne A; Jones CJ
    Anaesthesia; 1988 Nov; 43(11):930-4. PubMed ID: 3213918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Edrophonium antagonizes combined lidocaine-pancuronium and verapamil-pancuronium neuromuscular blockade in cats.
    Carpenter RL; Mulroy MF
    Anesthesiology; 1986 Nov; 65(5):506-10. PubMed ID: 3777479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromuscular and cardiovascular effects of high-dose vecuronium.
    Tullock WC; Diana P; Cook DR; Wilks DH; Brandom BW; Stiller RL; Beach CA
    Anesth Analg; 1990 Jan; 70(1):86-90. PubMed ID: 1967516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antagonism of an intubation dose of vecuronium].
    Sold M; Lazarus G; Baar H
    Anaesthesist; 1987 Jul; 36(7):345-51. PubMed ID: 2889392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
    Mills KG; Wright PM; Pollard BJ; Scott JM; Hing JP; Danjoux G; Hunter JM
    Br J Anaesth; 1999 Nov; 83(5):727-33. PubMed ID: 10690134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Edrophonium-hyoscine butylbromide mixture for reversal of neuromuscular blockade: heart rate changes in infants and children.
    Yamashita M; Tajima K
    Anaesthesia; 1988 Jul; 43(7):591-3. PubMed ID: 3414927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.